(Q42805035)
Statements
The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib (English)
Feihl S
Mugler C
Grundler R
von Bubnoff N
Lordick F
Peschel C
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference